Association between Early Treatment with Tocilizumab and Mortality among Critically Ill Patients with COVID-19

Shruti Gupta, Wei Wang, Salim S. Hayek, Lili Chan, Kusum S. Mathews, Michal L. Melamed, Samantha K. Brenner, Amanda Leonberg-Yoo, Edward J. Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Anand Srivastava, Yan Zhou, Diana Finkel, Adam Green, Mary Mallappallil, Anthony J. Faugno, Jingjing Zhang, Juan Carlos Q. VelezShahzad Shaefi, Chirag R. Parikh, David M. Charytan, Ambarish M. Athavale, Allon N. Friedman, Roberta E. Redfern, Samuel A.P. Short, Simon Correa, Kapil K. Pokharel, Andrew J. Admon, John P. Donnelly, Hayley B. Gershengorn, David J. Douin, Matthew W. Semler, Miguel A. Hernán, David E. Leaf

Research output: Contribution to journalArticlepeer-review

357 Scopus citations

Fingerprint

Dive into the research topics of 'Association between Early Treatment with Tocilizumab and Mortality among Critically Ill Patients with COVID-19'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology